Pioglitazone decreases diabetes, stroke risks in patients with prediabetes, cerebrovascular disease

Monday, August 01, 2016 by

In insulin-resistant patients with a recent ischemic stroke or transient ischemic attack, pioglitazone was shown to reduce the risk for developing type 2 diabetes and major cardiovascular events, according to an analysis of the IRIS trial.

(Article by healio.com)


comments powered by Disqus

Please like our Facebook Page
Show us your support by liking our page!
Close This Box